(CHEMM) ChemoMetec - Ratings and Ratios

Exchange: CO • Country: Denmark • Currency: DKK • Type: Common Stock • ISIN: DK0060055861

CHEMM: Cell Counters, Analyzers, Cytometers, Consumables, Accessories

ChemoMetec A/S is a company that specializes in the development, production, and sale of analytical equipment for cell counting and analysis, with a global presence spanning the United States, Canada, Europe, and international markets. The company's solutions cater to a diverse range of applications, including cell and gene therapy, cancer and stem cell research, and the development and manufacturing of pharmaceuticals. Additionally, their products are used in the production and quality control of animal semen, milk, and beer, highlighting the versatility of their technology.

The company's product portfolio includes a range of advanced analytical instruments, such as the NucleoCounter NC-3000, an image cytometer that provides high-resolution cell imaging and analysis. Other notable products include the NucleoCounter NC-250, an automated cell analyzer, and the NucleoCounter NC-202, a consistent cell counter that ensures accurate and reliable results. The NucleoCounter NC-200 is another key product, offering an automated solution for cell counting and cell viability determination. Furthermore, the company offers specialized products like the NucleoCounter SP-100, an automated sperm cell counter designed for use in animal reproduction, and the XcytoMatic 40, a cell density and viability analyzer that provides comprehensive insights into cell health and behavior.

In addition to its analytical instruments, ChemoMetec A/S also provides a range of consumables and accessories to support its products. These include cassettes, reagents, lysis, and slides, as well as cables, power supplies, software, and labware products. The company also offers service and validation plans, as well as training programs, to ensure that customers can optimize the use of their products and achieve the best possible results. Moreover, the company is continuously developing new products, such as the XcytoMatic 30 cell counter, which underscores its commitment to innovation and customer satisfaction. With its headquarters in Allerød, Denmark, and a history dating back to 1997, ChemoMetec A/S has established itself as a trusted partner in the life sciences industry.

As a publicly traded company, ChemoMetec A/S is listed under the ISIN code DK0060055861, with its common stock classified under the GICS Sub Industry of Life Sciences Tools & Services. The company's website, https://chemometec.com, provides further information on its products, services, and mission to deliver innovative solutions for cell counting and analysis. By leveraging its expertise and technology, ChemoMetec A/S aims to support advancements in various fields, from pharmaceutical development to animal reproduction, and contribute to the progress of the life sciences industry as a whole.

Additional Sources for CHEMM Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

CHEMM Stock Overview

Market Cap in USD 1,133m
Sector Healthcare
Industry Medical Devices
GiC Sub-Industry Life Sciences Tools & Services
IPO / Inception 2006-12-18

CHEMM Stock Ratings

Growth 5y 31.0%
Fundamental 70.9%
Dividend 6.38%
Rel. Strength Industry 1064
Analysts -
Fair Price Momentum 468.79 DKK
Fair Price DCF 140.67 DKK

CHEMM Dividends

Dividend Yield 12m 0.00%
Yield on Cost 5y %
Annual Growth 5y -100.00%
Payout Consistency 21.3%

CHEMM Growth Ratios

Growth Correlation 3m 90.3%
Growth Correlation 12m 38.5%
Growth Correlation 5y -12%
CAGR 5y 16.19%
CAGR/Mean DD 5y 0.45
Sharpe Ratio 12m 0.76
Alpha 8.44
Beta 1.23
Volatility 56.96%
Current Volume 21k
Average Volume 20d 41.1k
What is the price of CHEMM stocks?
As of January 22, 2025, the stock is trading at DKK 516.50 with a total of 21,010 shares traded.
Over the past week, the price has changed by +0.88%, over one month by +5.93%, over three months by +23.39% and over the past year by +38.99%.
Is ChemoMetec a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, ChemoMetec (CO:CHEMM) is currently (January 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 70.89 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CHEMM as of January 2025 is 468.79. This means that CHEMM is currently overvalued and has a potential downside of -9.24%.
Is CHEMM a buy, sell or hold?
ChemoMetec has no consensus analysts rating.
What are the forecast for CHEMM stock price target?
According to ValueRays Forecast Model, CHEMM ChemoMetec will be worth about 525.1 in January 2026. The stock is currently trading at 516.50. This means that the stock has a potential upside of +1.67%.
Issuer Forecast Upside
Wallstreet Target Price 545 5.5%
Analysts Target Price - -
ValueRay Target Price 525.1 1.7%